Currently, chemotherapeutic treatment approaches, such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) and targeted treatments such as Ibrutinib (BTK inhibitor) and Venetoclax (BCL2 inhibitor) are used to treat MCL. The gene discussed is BCL2; the disease is mantle cell lymphoma.